1 |
Show member pathways
|
13.82 |
TP53 SFTPC MYC KRAS HRAS H2AC18 |
2 |
Show member pathways
|
12.99 |
MYC KRAS HRAS H2AC18 EGFR AKT1 |
3 |
Show member pathways
|
12.95 |
TP53 MYC KRAS HRAS EGFR AKT1 |
4 |
Show member pathways
Apoptosis and survival TNFR1 signaling pathway
22
Apoptosis through Death Receptors
64
Apoptotic Pathways Triggered By HIV1
64
DR3 Signaling
64
GITR Pathway
64
TNF Signaling
64
TRAIL Pathway
64
TWEAK Pathway
64
|
12.94 |
TP53 MYC HRAS EGFR CDKN2A AKT1 |
5 |
Show member pathways
|
12.86 |
TP53 MYC KRAS HRAS AKT1 |
6 |
|
12.85 |
MYC KRAS HRAS EGFR AKT1 |
7 |
Show member pathways
|
12.78 |
TP53 MYC H2AC18 EGFR AKT1 |
8 |
Show member pathways
CRHR Pathway
64
GHRH Signaling
64
|
12.67 |
KRAS HRAS EGFR CDKN2A AKT1 |
9 |
Show member pathways
CD27 Pathway
64
CD40 Signaling
64
CMV and MAPK Pathways
64
NF-KappaB Activation by EBV
64
NF-kappaB Activation by Viruses
64
PKR Pathway
64
SUMO Pathway
64
TNFR2 Pathway
64
|
12.67 |
TP53 KRAS HRAS EGFR AKT1 |
10 |
|
12.65 |
TP53 MYC HRAS EGFR CDKN2A AKT1 |
11 |
Show member pathways
all-trans-Retinoic Acid Mediated Apoptosis
64
Cytokine Network
64
Immune response IFN alpha/beta signaling pathway
22
|
12.62 |
TP53 MYC KRAS HRAS EGFR AKT1 |
12 |
Show member pathways
Angiopoietin-TIE2 Signaling
64
Development Angiopoietin - Tie2 signaling
22
Development PDGF signaling via STATs and NF-kB
22
Immune response IL-10 signaling pathway
22
|
12.54 |
TP53 MYC KRAS HRAS EGFR AKT1 |
13 |
Show member pathways
Signal transduction PTEN pathway
22
|
12.49 |
TP53 MYC KRAS HRAS EGFR CDKN2A |
14 |
Show member pathways
Chemotaxis CXCR4 signaling pathway
22
Development Alpha-2 adrenergic receptor activation of ERK
22
|
12.42 |
KRAS HRAS EGFR AKT1 |
15 |
Show member pathways
|
12.42 |
TP53 KRAS HRAS EGFR AKT1 |
16 |
Show member pathways
|
12.37 |
TP53 MYC KRAS HRAS EGFR AKT1 |
17 |
Show member pathways
Development ERBB-family signaling
22
EGF Pathway
64
|
12.33 |
AKT1 EGFR HRAS KRAS MYC TP53 |
18 |
Show member pathways
Immune response IL-4 signaling pathway
22
Signal transduction AKT signaling
22
|
12.27 |
TP53 MYC HRAS AKT1 |
19 |
|
12.27 |
TP53 MYC KRAS HRAS EGFR AKT1 |
20 |
|
12.26 |
KRAS HRAS EGFR AKT1 |
21 |
Show member pathways
|
12.23 |
KRAS HRAS EGFR AKT1 |
22 |
|
12.19 |
AKT1 HRAS KRAS TP53 |
23 |
Show member pathways
|
12.16 |
KRAS HRAS EGFR AKT1 |
24 |
|
12.16 |
TP53 MYC KRAS EGFR AKT1 |
25 |
Show member pathways
|
12.16 |
TP53 MYC KRAS HRAS EGFR AKT1 |
26 |
Show member pathways
|
12.15 |
TP53 HRAS CDKN2A AKT1 |
27 |
Show member pathways
|
12.13 |
AKT1 HRAS KRAS MYC TP53 |
28 |
|
12.09 |
TP53 KRAS EGFR AKT1 |
29 |
|
12.09 |
TP53 MYC KRAS EGFR AKT1 |
30 |
Show member pathways
|
12.04 |
KRAS HRAS EGFR AKT1 |
31 |
|
11.9 |
TP53 MYC KRAS HRAS |
32 |
Show member pathways
Development EGFR signaling via PIP3
22
Development PDGF signaling via MAPK cascades
22
|
11.88 |
MYC KRAS HRAS EGFR AKT1 |
33 |
Show member pathways
|
11.8 |
KRAS HRAS AKT1 |
34 |
Show member pathways
|
11.77 |
AKT1 CDKN2A TP53 |
35 |
Show member pathways
|
11.77 |
TP53 KRAS HRAS AKT1 |
36 |
|
11.73 |
TP53 MYC CDKN2A |
37 |
|
11.73 |
MYC EGFR AKT1 |
38 |
|
11.72 |
TP53 MYC MIR106B |
39 |
|
11.7 |
MYC EGFR AKT1 |
40 |
|
11.68 |
TP53 HRAS AKT1 |
41 |
|
11.68 |
MYC KRAS HRAS EGFR CDKN2A AKT1 |
42 |
Show member pathways
|
11.66 |
KRAS HRAS AKT1 |
43 |
|
11.63 |
EGFR HRAS KRAS |
44 |
Show member pathways
TOB in T-Cell Signaling
64
|
11.62 |
MYC HRAS EGFR AKT1 |
45 |
|
11.61 |
TP53 MYC AKT1 |
46 |
|
11.57 |
TP53 CDKN2A AKT1 |
47 |
|
11.53 |
HRAS EGFR AKT1 |
48 |
|
11.42 |
KRAS HRAS AKT1 |
49 |
|
11.41 |
TP53 MYC AKT1 |
50 |
|
11.41 |
KRAS HRAS AKT1 |